David J. Chung

Indoleamine 2,3-dioxygenase–expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells

David J. Chung, Marco Rossi, Emanuela Romano et al. · Blood · 2009 · 259 citations · Full text

T-cell Exhaustion in Multiple Myeloma Relapse after Autotransplant: Optimal Timing of Immunotherapy

David J. Chung, Katherine B. Pronschinske, Justin A. Shyer et al. · Cancer Immunology Research · 2015 · 195 citations · Full text

T-regulatory Cell, Immunology, Immunoediting +20

Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma

Ola Landgren, Malin Hultcrantz, Benjamin Diamond et al. · JAMA Oncology · 2021 · 114 citations · Full text

Clinical Responses and Pharmacokinetics of MCARH171, a Human-Derived Bcma Targeted CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Final Results of a Phase I Clinical Trial

Sham Mailankody, Arnab Ghosh, Terence J. Purdon et al. · Blood · 2018 · 99 citations

Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial

Benjamin Diamond, Neha Korde, Alexander M. Lesokhin et al. · The Lancet Haematology · 2021 · 87 citations

Hematological Malignancy, Oncology, Continuous Lenalidomide Maintenance +7